Literature DB >> 7495082

Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets.

L Muszbek1, G Haramura, J Polgár.   

Abstract

The cellular form of blood coagulation factor XIII (FXIII) is present in platelets, monocytes and macrophages. During long-term stimulation of platelets by thrombin cellular FXIII becomes activated and cross-links proteins, however, the mechanism of its activation has not been elucidated. It was shown that, contrary to plasma FXIII, the intracellular activation of platelet FXIII does not involve proteolysis. FXIII remained intact in thrombin-activated platelets, i.e., the activation peptide was not removed from the molecule. Part of the zymogen FXIII molecules, however, assumed an active configuration as was demonstrated both by the measurement of transglutaminase activity and by active-site-SH titration. These findings clearly indicate that during platelet activation, when intracellular Ca2+ concentration is raised, a slow non-proteolytic transformation of FXIII zymogen into an active transglutaminase occurs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495082

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Reversible activation of cellular factor XIII by calcium.

Authors:  Gunhild Klarskov Kristiansen; Mette Dahl Andersen
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

2.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

3.  Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS.

Authors:  Ricky T Woofter; Muriel C Maurer
Journal:  Arch Biochem Biophys       Date:  2011-05-26       Impact factor: 4.013

4.  Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.

Authors:  Boris A Anokhin; William L Dean; Kerrie A Smith; Matthew J Flick; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  FEBS J       Date:  2019-08-28       Impact factor: 5.542

Review 5.  Regulation of the activities of the mammalian transglutaminase family of enzymes.

Authors:  Cornelius Klöck; Chaitan Khosla
Journal:  Protein Sci       Date:  2012-11-09       Impact factor: 6.725

Review 6.  Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.

Authors:  Alisa S Wolberg; Yaqiu Sang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-02       Impact factor: 10.514

Review 7.  Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.

Authors:  Alisa S Wolberg
Journal:  Curr Opin Hematol       Date:  2018-09       Impact factor: 3.284

8.  Preliminary investigation of the dissolution behavior, cytocompatibility, effects of fibrinogen conformation and platelet adhesion for radiopaque embolic particles.

Authors:  Sharon Kehoe; Marie-Laurence Tremblay; Aisling Coughlan; Mark R Towler; Jan K Rainey; Robert J Abraham; Daniel Boyd
Journal:  J Funct Biomater       Date:  2013-07-10

9.  Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization.

Authors:  M Nurminskaya; C Magee; D Nurminsky; T F Linsenmayer
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

10.  Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.

Authors:  Zsuzsanna Z Orosz; Helga Bárdos; Amir H Shemirani; Ildikó Beke Debreceni; Riitta Lassila; Antti S Riikonen; Johanna A Kremer Hovinga; Theo G Seiler; Hendrika A van Dorland; Verena Schroeder; Zoltán Boda; László Nemes; Beatrice Früh Eppstein; Bence Nagy; Andrea Facskó; János Kappelmayer; László Muszbek
Journal:  Int J Mol Sci       Date:  2019-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.